Viatris, Inc. (VTRS)
16.52
+0.04
(+0.21%)
USD |
NASDAQ |
May 18, 13:40
Viatris Research and Development Expense (Quarterly) : 245.20M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.452B |
| Theravance Biopharma, Inc. | 5.448M |
| Eli Lilly & Co. | 3.51B |
| Merck & Co., Inc. | 11.98B |
| Bristol Myers Squibb Co. | 2.238B |